Palatin Technologies Inc (PTN)

Currency in USD
5.150
-0.210(-3.92%)
Closed·
5.1500.000(0.00%)
·
PTN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5.1105.500
52 wk Range
4.51031.000
Key Statistics
Prev. Close
5.15
Open
5.4
Day's Range
5.11-5.5
52 wk Range
4.51-31
Volume
11.18K
Average Volume (3m)
70.73K
1-Year Change
-62.6812%
Book Value / Share
1.14
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PTN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Palatin Technologies Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Palatin Technologies Inc Earnings Call Summary for Q1/2027

  • Palatin posted Q1 FY2027 loss of $1.29/share vs. consensus $4.26 profit; revenue fell to $3M as collaboration income dropped 96% YoY to $362K.
  • Stock plunged 14% to $5.26 on cash concerns; company ended quarter with just $3.7M cash, equal to quarterly burn rate, requiring near-term financing.
  • Lead lipidated MC4R obesity peptide remains on track for Q2 2027 IND filing, H1 2027 Phase I start, and H2 2027 initial data readout.
  • Management exploring public/private equity and strategic partnerships as partner interest surges around validated MC4R obesity pathway following Rhythm's success.
  • R&D spending jumped 36% to $3.4M as company advances differentiated MC4R programs targeting improved tolerability and reduced hyperpigmentation vs. competitors.
Last Updated: 11/18/2026, 12:50 AM
Read Full Transcript

Earnings

Latest Release
Nov 17, 2026
EPS / Forecast
-1.29 / 4.26
Revenue / Forecast
361.8K / --
EPS Revisions
Last 90 days

PTN Income Statement

Compare PTN to Peers and Sector

Metrics to compare
PTN
Peers
Sector
Relationship
P/E Ratio
−0.5x−1.7x−0.2x
PEG Ratio
−0.02−0.030.00
Price/Book
4.8x2.3x2.6x
Price / LTM Sales
2.1x6.9x2.7x
Upside (Analyst Target)
-151.6%69.6%
Fair Value Upside
Unlock7.1%11.7%Unlock

Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity completed Phase 2 clinical trial; completed a phase 2 of diabetic nephropathy It also provides pl9643 for dry eye disease; and oral PL8177 for inflammatory bowel diseases. licensing arrangements and other strategic transactions to advance and maximize the value of certain product candidates and program for the treatment of retinal diseases and with Altanispac Labs for PL9643 for the treatment of dry eye disease; and oral PL8177 for the treatment inflammatory bowel diseases. Palatin Technologies, Inc. was incorporated in 1986 and is based in Princeton, New Jersey.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
50.98K2.86%312.23K
Other Institutional Investors
1.30M73.02%7.96M
Public Companies & Retail Investors
429.59K24.12%2.63M
Total
1.78M100.00%10.91M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Driehaus Capital Management LLC9.36%166,7131,021
Janus Henderson Group Ltd.7.86%140,000858

People Also Watch

154.16
EPAM
+0.01%
8.36
CTVA
-5.22%
338.34
ETN
+0.36%
29.90
CSGP
-2.26%
32.180
INOD
-0.71%

FAQ

What Is the Palatin Tech (PTN) Stock Price Today?

The Palatin Tech stock price today is 5.150 USD.

What Stock Exchange Does Palatin Tech Trade On?

Palatin Tech is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Palatin Tech?

The stock symbol for Palatin Tech is "PTN."

What Is the Palatin Tech Market Cap?

As of today, Palatin Tech market cap is 9.800M USD.

What Is Palatin Tech's Earnings Per Share (TTM)?

The Palatin Tech EPS (TTM) is -5.08.

When Is the Next Palatin Tech Earnings Date?

Palatin Tech will release its next earnings report on Feb 17, 2027.

From a Technical Analysis Perspective, Is PTN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Palatin Tech Stock Split?

Palatin Tech has split 1 times.

How Many Employees Does Palatin Tech Have?

Palatin Tech has 25 employees.

What is the current trading status of Palatin Tech (PTN)?

As of Nov 19, 2026, Palatin Tech (PTN) is trading at a price of 5.150 USD, with a previous close of 5.150 USD. The stock has fluctuated within a day range of 5.110 USD to 5.500 USD, while its 52-week range spans from 4.510 USD to 31.000 USD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.